Intelgenx Technologies Corp Asset Turnover Ratio (IGXT), as of first quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Intelgenx Technologies Corp   (IGXT)
 

Intelgenx Technologies Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Intelgenx Technologies Corp asset turnover ratio, the ability of Intelgenx Technologies Corp 's assets to generate revenue in the first quarter 2024, increased sequentially to 0.12 in the first quarter (Mar 31 2024), yet the ratio remained below the average, as IGXT's position remain challenging.

Within sector 191 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2024 compared to the preceding quarter from 3138 to 3430.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IGXT Asset Turnover Ratio (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Asset Change -37.89 % -9.56 % -29.75 % 0.23 % -43.4 %
Y / Y Revenue Change 7.41 % 141.04 % 123.94 % -66.58 % -31.65 %
Asset Turnover Ratio (TTM) 0.12 0.11 0.08 0.06 0.08
IGXT's Total Ranking # 3430 # 3138 # 3487 # 3044 #
Seq. Asset Change -21.52 % 2.92 % -44.3 % 38.04 % 14.27 %
Seq. Revenue Change -58.27 % 31.13 % 139.1 % -17.9 % -6.36 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 192
Healthcare Sector # 538
Overall Market # 3430

Asset Turnover Ratio Statistics
High Average Low
17.96 5.79 1.08
(Sep. 30, 2014)   (Jun 30 2020)




IGXT Company Profile • Back to IGXT Efficiency Comparisons • Compare IGXT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Assets at quarter ending Mar 31 2024
Halozyme Therapeutics Inc   0.47 $ 862.989  Millions$ 1,819.475  Millions
Scilex Holding Company  0.47 $ 47.045  Millions$ 99.885  Millions
Artivion Inc   0.47 $ 366.893  Millions$ 782.263  Millions
Sight Sciences Inc   0.47 $ 79.823  Millions$ 171.035  Millions
Logicmark Inc  0.47 $ 9.731  Millions$ 20.887  Millions
Ensysce Biosciences Inc   0.47 $ 2.101  Millions$ 4.514  Millions
Nexgel Inc   0.46 $ 4.736  Millions$ 10.196  Millions
Supernus Pharmaceuticals inc   0.46 $ 597.401  Millions$ 1,290.006  Millions
Lifecore Biomedical Inc   0.46 $ 114.100  Millions$ 247.806  Millions
Novocure Limited  0.46 $ 525.659  Millions$ 1,143.232  Millions
Vertex Pharmaceuticals Inc  0.46 $ 10,185.000  Millions$ 22,180.750  Millions
Cumberland Pharmaceuticals Inc   0.46 $ 38.826  Millions$ 85.103  Millions
Inmed Pharmaceuticals Inc  0.45 $ 6.218  Millions$ 13.752  Millions
Gilead Sciences Inc   0.45 $ 27,450.000  Millions$ 60,781.750  Millions
Amphastar Pharmaceuticals Inc   0.45 $ 676.209  Millions$ 1,502.532  Millions
Immucell Corporation  0.45 $ 19.702  Millions$ 43.853  Millions
Revance Therapeutics Inc   0.45 $ 236.645  Millions$ 529.149  Millions
Regen Biopharma Inc   0.45 $ 0.127  Millions$ 0.283  Millions
Hologic Inc  0.44 $ 3,960.600  Millions$ 8,915.275  Millions
Sarepta Therapeutics Inc   0.44 $ 1,403.300  Millions$ 3,181.139  Millions
Pacira Biosciences inc   0.44 $ 681.754  Millions$ 1,558.638  Millions
Biomerica Inc   0.43 $ 5.405  Millions$ 12.462  Millions
American Shared Hospital Services  0.43 $ 20.562  Millions$ 47.525  Millions
Globus Medical Inc   0.43 $ 1,898.454  Millions$ 4,399.509  Millions
Bio techne Corp  0.43 $ 1,153.683  Millions$ 2,688.479  Millions
Axsome Therapeutics Inc   0.43 $ 251.023  Millions$ 586.615  Millions
Illumina Inc   0.43 $ 4,493.000  Millions$ 10,511.750  Millions
Transmedics Group Inc   0.42 $ 296.919  Millions$ 702.366  Millions
Perrigo Company Plc  0.42 $ 4,554.900  Millions$ 10,793.100  Millions
Boston Scientific Corporation  0.42 $ 14,709.000  Millions$ 34,862.250  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.